Log In
person
Qiagen NV
QGEN
summarize
4 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Life Science Products |
Genetic, Genomic, and Sequencing Equipment for Life Science Research
These companies manufacture life science research equipment such as genetic, genomic, and sequencing equipment for pharmaceutical manufacturers and sell directly to their customers.
|
901.9M | 45.89% |
| Life Science Products |
Genetic, Genomic, and Sequencing Equipment for Medical Diagnostics
These companies manufacture genetic, genomic, and sequencing equipment for diagnostics.
|
697.63M | 35.50% |
| Life Science Products |
Genetic, Genomic, and Sequencing Kits
These companies manufacture genetic, genomic, assay, and sequencing test kits.
|
300.2M | 15.28% |
| Life Science Products |
Licensing of Patents for Diagnostic Testing
These companies develop tests for diagnosing patients, and license their patented diagnostic technology to healthcare companies.
|
65.58M | 3.34% |
| keyboard_arrow_down |
Life Science Products
Genetic, Genomic, and Sequencing Equipment for Life Science Research
|
901.9M | 45.89% |
| keyboard_arrow_right |
These companies manufacture life science research equipment such as genetic, genomic, and sequencing equipment for pharmaceutical manufacturers and sell directly to their customers.
|
||
| keyboard_arrow_down |
Life Science Products
Genetic, Genomic, and Sequencing Equipment for Medical Diagnostics
|
697.63M | 35.50% |
| keyboard_arrow_right |
These companies manufacture genetic, genomic, and sequencing equipment for diagnostics.
|
||
| keyboard_arrow_down |
Life Science Products
Genetic, Genomic, and Sequencing Kits
|
300.2M | 15.28% |
| keyboard_arrow_right |
These companies manufacture genetic, genomic, assay, and sequencing test kits.
|
||
| keyboard_arrow_down |
Life Science Products
Licensing of Patents for Diagnostic Testing
|
65.58M | 3.34% |
| keyboard_arrow_right |
These companies develop tests for diagnosing patients, and license their patented diagnostic technology to healthcare companies.
|
||